These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38367301)
1. SAMHD1 dysfunction induces IL-34 expression via NF-κB p65 in neuronal SH-SY5Y cells. Zhang L; Wang W; Chen T; Cui J; Li X; Liu A; Liu R; Fang L; Jiang J; Yang L; Wu D; Ying S Mol Immunol; 2024 Apr; 168():1-9. PubMed ID: 38367301 [TBL] [Abstract][Full Text] [Related]
2. [miR-155-5p alleviates lipopolysaccharide-induced inflammatory damage of human SH-SY5Y neuroblastoma cells by down-regulating SOCS1]. Zhou H; Zhou L; Zhang C; Zhou L; Han Y Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):220-229. PubMed ID: 36946346 [TBL] [Abstract][Full Text] [Related]
3. TRAF6 and TAK1 Contribute to SAMHD1-Mediated Negative Regulation of NF-κB Signaling. Espada CE; St Gelais C; Bonifati S; Maksimova VV; Cahill MP; Kim SH; Wu L J Virol; 2021 Jan; 95(3):. PubMed ID: 33177202 [TBL] [Abstract][Full Text] [Related]
4. A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans. White TE; Brandariz-Nuñez A; Martinez-Lopez A; Knowlton C; Lenzi G; Kim B; Ivanov D; Diaz-Griffero F Hum Mutat; 2017 Jun; 38(6):658-668. PubMed ID: 28229507 [TBL] [Abstract][Full Text] [Related]
5. SAMHD1 suppresses innate immune responses to viral infections and inflammatory stimuli by inhibiting the NF-κB and interferon pathways. Chen S; Bonifati S; Qin Z; St Gelais C; Kodigepalli KM; Barrett BS; Kim SH; Antonucci JM; Ladner KJ; Buzovetsky O; Knecht KM; Xiong Y; Yount JS; Guttridge DC; Santiago ML; Wu L Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3798-E3807. PubMed ID: 29610295 [TBL] [Abstract][Full Text] [Related]
6. Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutieres syndrome. Cuadrado E; Jansen MH; Anink J; De Filippis L; Vescovi AL; Watts C; Aronica E; Hol EM; Kuijpers TW Brain; 2013 Jan; 136(Pt 1):245-58. PubMed ID: 23365100 [TBL] [Abstract][Full Text] [Related]
7. [SAMHD1 acts at stalled replication forks to prevent interferon induction]. Coquel F; Silva MJ; Técher H; Zadorozhny K; Sharma S; Nieminuszczy J; Mettling C; Dardillac E; Barthe A; Schmitz AL; Promonet A; Cribier A; Sarrazin A; Niedzwiedz W; Lopez B; Costanzo V; Krejci L; Chabes A; Benkirane M; Lin YL; Pasero P C R Biol; 2020 Jun; 343(1):9-21. PubMed ID: 32720483 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis induced by trimethyltin chloride in human neuroblastoma cells SY5Y is regulated by a balance and cross-talk between NF-κB and MAPKs signaling pathways. Qing Y; Liang Y; Du Q; Fan P; Xu H; Xu Y; Shi N Arch Toxicol; 2013 Jul; 87(7):1273-85. PubMed ID: 23423712 [TBL] [Abstract][Full Text] [Related]
9. Recombinant Klotho attenuates IFNγ receptor signaling and SAMHD1 expression through blocking NF-κB translocation in glomerular mesangial cells. Tsai KD; Lee YC; Chen BY; Wu LS; Liang SY; Liu MY; Hung YW; Hsu HL; Chen PQ; Shieh JC; Lee YJ; Lin TH Int J Med Sci; 2023; 20(6):810-817. PubMed ID: 37213666 [TBL] [Abstract][Full Text] [Related]
10. Elimination of Aicardi-Goutières syndrome protein SAMHD1 activates cellular innate immunity and suppresses SARS-CoV-2 replication. Oo A; Zandi K; Shepard C; Bassit LC; Musall K; Goh SL; Cho YJ; Kim DH; Schinazi RF; Kim B J Biol Chem; 2022 Mar; 298(3):101635. PubMed ID: 35085552 [TBL] [Abstract][Full Text] [Related]
12. Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutières syndrome-related SAMHD1. Zhao K; Du J; Han X; Goodier JL; Li P; Zhou X; Wei W; Evans SL; Li L; Zhang W; Cheung LE; Wang G; Kazazian HH; Yu XF Cell Rep; 2013 Sep; 4(6):1108-15. PubMed ID: 24035396 [TBL] [Abstract][Full Text] [Related]
13. SAMHD1-deficient fibroblasts from Aicardi-Goutières Syndrome patients can escape senescence and accumulate mutations. Franzolin E; Coletta S; Ferraro P; Pontarin G; D'Aronco G; Stevanoni M; Palumbo E; Cagnin S; Bertoldi L; Feltrin E; Valle G; Russo A; Bianchi V; Rampazzo C FASEB J; 2020 Jan; 34(1):631-647. PubMed ID: 31914608 [TBL] [Abstract][Full Text] [Related]
14. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection. Berger A; Sommer AF; Zwarg J; Hamdorf M; Welzel K; Esly N; Panitz S; Reuter A; Ramos I; Jatiani A; Mulder LC; Fernandez-Sesma A; Rutsch F; Simon V; König R; Flory E PLoS Pathog; 2011 Dec; 7(12):e1002425. PubMed ID: 22174685 [TBL] [Abstract][Full Text] [Related]
15. Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. Powell RD; Holland PJ; Hollis T; Perrino FW J Biol Chem; 2011 Dec; 286(51):43596-43600. PubMed ID: 22069334 [TBL] [Abstract][Full Text] [Related]
16. SAMHD1 is a nucleic-acid binding protein that is mislocalized due to aicardi-goutières syndrome-associated mutations. Goncalves A; Karayel E; Rice GI; Bennett KL; Crow YJ; Superti-Furga G; Bürckstümmer T Hum Mutat; 2012 Jul; 33(7):1116-22. PubMed ID: 22461318 [TBL] [Abstract][Full Text] [Related]
17. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Crow YJ; Chase DS; Lowenstein Schmidt J; Szynkiewicz M; Forte GM; Gornall HL; Oojageer A; Anderson B; Pizzino A; Helman G; Abdel-Hamid MS; Abdel-Salam GM; Ackroyd S; Aeby A; Agosta G; Albin C; Allon-Shalev S; Arellano M; Ariaudo G; Aswani V; Babul-Hirji R; Baildam EM; Bahi-Buisson N; Bailey KM; Barnerias C; Barth M; Battini R; Beresford MW; Bernard G; Bianchi M; Billette de Villemeur T; Blair EM; Bloom M; Burlina AB; Carpanelli ML; Carvalho DR; Castro-Gago M; Cavallini A; Cereda C; Chandler KE; Chitayat DA; Collins AE; Sierra Corcoles C; Cordeiro NJ; Crichiutti G; Dabydeen L; Dale RC; D'Arrigo S; De Goede CG; De Laet C; De Waele LM; Denzler I; Desguerre I; Devriendt K; Di Rocco M; Fahey MC; Fazzi E; Ferrie CD; Figueiredo A; Gener B; Goizet C; Gowrinathan NR; Gowrishankar K; Hanrahan D; Isidor B; Kara B; Khan N; King MD; Kirk EP; Kumar R; Lagae L; Landrieu P; Lauffer H; Laugel V; La Piana R; Lim MJ; Lin JP; Linnankivi T; Mackay MT; Marom DR; Marques Lourenço C; McKee SA; Moroni I; Morton JE; Moutard ML; Murray K; Nabbout R; Nampoothiri S; Nunez-Enamorado N; Oades PJ; Olivieri I; Ostergaard JR; Pérez-Dueñas B; Prendiville JS; Ramesh V; Rasmussen M; Régal L; Ricci F; Rio M; Rodriguez D; Roubertie A; Salvatici E; Segers KA; Sinha GP; Soler D; Spiegel R; Stödberg TI; Straussberg R; Swoboda KJ; Suri M; Tacke U; Tan TY; te Water Naude J; Wee Teik K; Thomas MM; Till M; Tonduti D; Valente EM; Van Coster RN; van der Knaap MS; Vassallo G; Vijzelaar R; Vogt J; Wallace GB; Wassmer E; Webb HJ; Whitehouse WP; Whitney RN; Zaki MS; Zuberi SM; Livingston JH; Rozenberg F; Lebon P; Vanderver A; Orcesi S; Rice GI Am J Med Genet A; 2015 Feb; 167A(2):296-312. PubMed ID: 25604658 [TBL] [Abstract][Full Text] [Related]
18. Single-stranded nucleic acids promote SAMHD1 complex formation. Tüngler V; Staroske W; Kind B; Dobrick M; Kretschmer S; Schmidt F; Krug C; Lorenz M; Chara O; Schwille P; Lee-Kirsch MA J Mol Med (Berl); 2013 Jun; 91(6):759-70. PubMed ID: 23371319 [TBL] [Abstract][Full Text] [Related]
19. The dNTPase activity of SAMHD1 is important for its suppression of innate immune responses in differentiated monocytic cells. Qin Z; Bonifati S; St Gelais C; Li TW; Kim SH; Antonucci JM; Mahboubi B; Yount JS; Xiong Y; Kim B; Wu L J Biol Chem; 2020 Feb; 295(6):1575-1586. PubMed ID: 31914403 [TBL] [Abstract][Full Text] [Related]
20. Aicardi-Goutières syndrome and systemic lupus erythematosus (SLE) in a 12-year-old boy with SAMHD1 mutations. Ramantani G; Häusler M; Niggemann P; Wessling B; Guttmann H; Mull M; Tenbrock K; Lee-Kirsch MA J Child Neurol; 2011 Nov; 26(11):1425-8. PubMed ID: 21670392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]